AAPM Task Group Report 307: Use of EPIDs for Patient‐Specific IMRT and VMAT QA
Authors:
Top Cited Papers
Open Access
- 29 June 2023
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 50 (8) , E865-E903
Abstract
Purpose: Electronic portal imaging devices (EPIDs) have been widely utilized for patient‐specific quality assurance (PSQA) and their use for transit dosimetry applications is emerging. Yet there are no specific guidelines on the potential uses, limitations, and correct utilization of EPIDs for these purposes. The American Association of Physicists in Medicine (AAPM) Task Group 307 (TG‐307) provides a comprehensive review of the physics, modeling, algorithms and clinical experience with EPID‐based pre‐treatment and transit dosimetry techniques. This review also includes the limitations and challenges in the clinical implementation of EPIDs, including recommendations for commissioning, calibration and validation, routine QA, tolerance levels for gamma analysis and risk‐based analysis.Methods: Characteristics of the currently available EPID systems and EPID‐based PSQA techniques are reviewed. The details of the physics, modeling, and algorithms for both pre‐treatment and transit dosimetry methods are discussed, including clinical experience with different EPID dosimetry systems. Commissioning, calibration, and validation, tolerance levels and recommended tests, are reviewed, and analyzed. Risk‐based analysis for EPID dosimetry is also addressed.Results: Clinical experience, commissioning methods and tolerances for EPID‐based PSQA system are described for pre‐treatment and transit dosimetry applications. The sensitivity, specificity, and clinical results for EPID dosimetry techniques are presented as well as examples of patient‐related and machine‐related error detection by these dosimetry solutions. Limitations and challenges in clinical implementation of EPIDs for dosimetric purposes are discussed and acceptance and rejection criteria are outlined. Potential causes of and evaluations of pre‐treatment and transit dosimetry failures are discussed. Guidelines and recommendations developed in this report are based on the extensive published data on EPID QA along with the clinical experience of the TG‐307 members.Conclusion: TG‐307 focused on the commercially available EPID‐based dosimetric tools and provides guidance for medical physicists in the clinical implementation of EPID‐based patient‐specific pre‐treatment and transit dosimetry QA solutions including intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) treatments.Keywords
This publication has 151 references indexed in Scilit:
- A novel technique for VMAT QA with EPID in cine mode on a Varian TrueBeam linacPhysics in Medicine & Biology, 2013
- A system for EPID‐based real‐time treatment delivery verification during dynamic IMRT treatmentMedical Physics, 2013
- Measured vs simulated portal images for low MU fields on three accelerator types: Possible consequences for 2D portal dosimetryMedical Physics, 2012
- In aqua vivo EPID dosimetryMedical Physics, 2011
- Quality assurance of RapidArc in clinical practice using portal dosimetryBritish Journal of Radiology, 2011
- Quality assurance of volumetric modulated arc therapy: Evaluation and comparison of different dosimetric systemsMedical Physics, 2011
- In vivo dose verification from back projection of a transit dose measurement on the central axis of photon beamsPhysica Medica, 2011
- Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification within vivodosimetryBritish Journal of Radiology, 2010
- 3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetryRadiotherapy and Oncology, 2010
- EPID dosimetry: Effect of different layers of materials on absorbed dose responseMedical Physics, 2009